** Shares of Cyclopharm CYC.AX rise 6.6% to A$1.525, their highest level since February 27
** Radiopharmaceutical co says its signed a 5-year agreement with USA Veterans Administration
** The five-year Federal Supply Schedule $(FSS)$ agreement works to expand co's medical radioactive technology Technegas’ adoption within the US federal healthcare system
** Stock set for second straight session of gains
** CYC up 4.7% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))